• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

新辅助同步放化疗联合食管癌切除术治疗食管癌：新发房颤的治疗结果

Neoadjuvant Concurrent Chemoradiation and Esophagectomy for Esophageal Cancer: Outcomes With New-Onset Atrial Fibrillation.

作者信息

Byer Stefano H, Sivamurugan Aravinthasamy, Grewal Udhayvir S

机构信息

Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa, US.

Carver College of Medicine, University of Iowa, Iowa City, Iowa, US.

出版信息

Thorac Cancer. 2025 Jan;16(1):e15518. doi: 10.1111/1759-7714.15518.

DOI:10.1111/1759-7714.15518
PMID:39788889
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11726696/
Abstract

This illustrates the outcomes of patients with esophageal cancer undergoing neoadjuvant concurrent chemoradiation and esophagectomy, specifically focusing on those who develop new-onset atrial fibrillation (NOAF). Statistically significant findings (p < 0.05, dark red) increased mortality and ventricular fibrillation, as well as trends of (p > 0.05, light red) myocardial infarction and pericardial effusion among NOAF patients. The data emphasize the significant cardiovascular risks associated with NOAF in this population.

摘要

这展示了接受新辅助同步放化疗和食管切除术的食管癌患者的治疗结果，特别关注那些出现新发房颤（NOAF）的患者。具有统计学意义的结果（p < 0.05，深红色）显示NOAF患者的死亡率和心室颤动增加，以及（p > 0.05，浅红色）心肌梗死和心包积液的趋势。这些数据强调了该人群中与NOAF相关的重大心血管风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/747d/11726696/16d59cbb7003/TCA-16-e15518-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/747d/11726696/16d59cbb7003/TCA-16-e15518-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/747d/11726696/16d59cbb7003/TCA-16-e15518-g002.jpg

相似文献

1
Neoadjuvant Concurrent Chemoradiation and Esophagectomy for Esophageal Cancer: Outcomes With New-Onset Atrial Fibrillation.新辅助同步放化疗联合食管癌切除术治疗食管癌：新发房颤的治疗结果
Thorac Cancer. 2025 Jan;16(1):e15518. doi: 10.1111/1759-7714.15518.
2
Esophagectomy Timing After Neoadjuvant Therapy for Distal Esophageal Adenocarcinoma.新辅助治疗后远端食管腺癌的食管切除术时机
Ann Thorac Surg. 2016 Mar;101(3):1123-30. doi: 10.1016/j.athoracsur.2015.09.044. Epub 2015 Dec 1.
3
Neoadjuvant Chemotherapy versus Chemoradiation Prior to Esophagectomy: Impact on Rate of Complete Pathologic Response and Survival in Esophageal Cancer Patients.食管癌切除术前新辅助化疗与放化疗的比较：对食管癌患者完全病理缓解率和生存率的影响
J Thorac Oncol. 2016 Dec;11(12):2227-2237. doi: 10.1016/j.jtho.2016.07.031. Epub 2016 Aug 17.
4
Does timing of esophagectomy following neoadjuvant chemoradiation affect outcomes? A meta-analysis.新辅助放化疗后行食管切除术的时机是否影响疗效？一项荟萃分析。
Int J Surg. 2018 Nov;59:11-18. doi: 10.1016/j.ijsu.2018.09.013. Epub 2018 Sep 24.
5
Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.新辅助放化疗与单纯化疗用于接受食管癌切除术的患者的比较。
Ann Thorac Surg. 2008 Apr;85(4):1217-23; discussion 1223-4. doi: 10.1016/j.athoracsur.2007.11.070.
6
Hybrid minimally invasive Ivor Lewis esophagectomy after neoadjuvant chemoradiation yields excellent long-term survival outcomes with minimal morbidity.新辅助放化疗后行杂交微创Ivor Lewis食管癌切除术可获得极佳的长期生存结果，且并发症极少。
J Surg Oncol. 2016 Dec;114(7):838-847. doi: 10.1002/jso.24409. Epub 2016 Aug 28.
7
Neoadjuvant chemoradiation is associated with improved overall survival in older patients with esophageal cancer.新辅助放化疗可改善老年食管癌患者的总生存。
J Geriatr Oncol. 2018 Jan;9(1):40-46. doi: 10.1016/j.jgo.2017.08.010. Epub 2017 Sep 6.
8
CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cTNM) (NCT03001596).CMISG1701：一项多中心前瞻性随机III期临床试验，比较新辅助放化疗与新辅助化疗后行微创食管切除术在局部晚期可切除食管鳞状细胞癌（cTNM）患者中的疗效（NCT03001596）。
BMC Cancer. 2017 Jun 28;17(1):450. doi: 10.1186/s12885-017-3446-7.
9
Radiation With Neoadjuvant Chemotherapy Does Not Improve Outcomes in Esophageal Squamous Cell Cancer.放化疗不能改善食管鳞癌的预后。
J Surg Res. 2019 Apr;236:259-265. doi: 10.1016/j.jss.2018.11.052. Epub 2018 Dec 24.
10
Low- vs. High-Dose Neoadjuvant Radiation in Trimodality Treatment of Locally Advanced Esophageal Cancer.低剂量与高剂量新辅助放疗在局部进展期食管癌三联治疗中的比较。
J Gastrointest Surg. 2019 May;23(5):885-894. doi: 10.1007/s11605-018-4007-3. Epub 2018 Oct 29.

本文引用的文献

1
Risk factors for the development of postoperative atrial fibrillation after esophagectomy for esophageal cancer.食管癌手术后心房颤动发生的危险因素。
Medicine (Baltimore). 2023 Sep 22;102(38):e35183. doi: 10.1097/MD.0000000000035183.
2
Incident Atrial Fibrillation and Survival Outcomes in Esophageal Cancer following Radiotherapy.放疗后食管癌并发心房颤动与生存结局。
Int J Radiat Oncol Biol Phys. 2024 Jan 1;118(1):124-136. doi: 10.1016/j.ijrobp.2023.08.011. Epub 2023 Aug 12.
3
Cardiac Adverse Events Associated With Chemo-Radiation Versus Chemotherapy for Resectable Stage III Non-Small-Cell Lung Cancer: A Surveillance, Epidemiology and End Results-Medicare Study.
放化疗与单纯化疗治疗可切除 III 期非小细胞肺癌的心脏不良事件：监测、流行病学和最终结果-医疗保险研究。
J Am Heart Assoc. 2022 Dec 6;11(23):e027288. doi: 10.1161/JAHA.122.027288. Epub 2022 Dec 1.
4
Risk of Atrial Fibrillation According to Cancer Type: A Nationwide Population-Based Study.根据癌症类型分析心房颤动的风险：一项基于全国人口的研究。
JACC CardioOncol. 2021 Jun 15;3(2):221-232. doi: 10.1016/j.jaccao.2021.03.006. eCollection 2021 Jun.
5
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial.新辅助放化疗联合手术治疗食管癌的 10 年结果：随机对照 CROSS 试验。
J Clin Oncol. 2021 Jun 20;39(18):1995-2004. doi: 10.1200/JCO.20.03614. Epub 2021 Apr 23.
6
Clinical factors associated with the development of postoperative atrial fibrillation in esophageal cancer patients receiving multimodality therapy before surgery.术前接受多模式治疗的食管癌患者术后房颤发生的相关临床因素。
J Gastrointest Oncol. 2020 Feb;11(1):68-75. doi: 10.21037/jgo.2019.12.05.
7
New-onset atrial fibrillation after esophagectomy for cancer.癌症食管癌切除术后新发房颤
J Thorac Dis. 2019 Apr;11(Suppl 5):S831-S834. doi: 10.21037/jtd.2019.02.03.
8
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018：GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
9
Association between Postoperatively Developed Atrial Fibrillation and Long-Term Mortality after Esophagectomy in Esophageal Cancer Patients: An Observational Study.食管癌患者食管癌切除术后新发房颤与长期死亡率的关联：一项观察性研究
PLoS One. 2016 May 5;11(5):e0154931. doi: 10.1371/journal.pone.0154931. eCollection 2016.